Technavio says global cerebral and tissue oximetry market worth $128.3 million by 2020

Renewable energy


This market research report presents a comprehensive analysis of the global cerebral and tissue oximetry market by key regions such as the Americas, APAC, and EMEA. Key vendors in this market are CAS Medical Systems, Masimo, Medtronic, and Nonin Medical.

Technavio’s market research analysts estimate the global cerebral and tissue oximetry market to grow at a CAGR of around 7% between 2016 and 2020. Cerebral hypoxia is becoming prevalent worldwide, and its chances increase in people undergoing cardiovascular, thoracic, and neurological surgeries. Physicians use cerebral and tissue oximeters to monitor the oxygen levels in the brain and prevent mortality due to the condition.     The rising cases of cerebral hypoxia worldwide are leading to the demand for cerebral and tissue oximeters. The Americas dominate the cerebral and tissue oximetry market globally, accounting for around 61% of the total market share. The availability of advanced technologies has helped vendors develop innovative oximeters that provide accurate results and improve medical outcomes.

The new market research report from Technavio provides a breakdown and analysis of the cerebral and tissue oximetry segments by technology.

“Vendors are using available technologies to develop advanced cerebral and tissue oximeters like the dual parameter tissue oximeter. This device operates by obtaining a patient’s pulse as well as regional oximetry measurements. For example, Nonin Medical’s SenSmart Model X-100 is such a device and capable of measuring other parameters as well, depending on requirement. Medical facilities which have invested in this device have been able to save patients and also reduce equipment-related expenditure. Extensive use of this device by medical facilities will help in propelling the oximetry market during the forecast period and into the future,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research

Cerebral and tissue oximetry devices employ near-infrared spectroscopy technology for monitoring cerebral oxygenation levels. This technology allows constant monitoring of neurological responses to a particular intervention or stimulus. The incorporation of this technology in cerebral and tissue oximetry devices has helped medical personnel to increase medical outcomes. Covidien’s INVOS system, Hamamatsu’s NIRO systems, and CAS Medical Systems’ FORE-SIGHT and FORE-SIGHT ELITE are some of these devices that employ near-infrared spectroscopy technology to monitor oxygen levels.

The leading vendors in the global cerebral and tissue oximetry market include CAS Medical Systems, Masimo, Medtronic, and Nonin Medical. The market is quite fragmented, with the presence of a number of vendors. Competition is very high and is expected to intensify during the forecast period. Since vendors have similar products, they have to find ways to retain and capture new market share. Some companies go through mergers to consolidate market share and gain entry into emerging markets. 

A more detailed analysis is available in the Technavio report, Global Cerebral and Tissue Oximetry Market 2016-2020.

We can customize reports by other regions and specific segments upon request.

Other related reports: